Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Pharmacological Research|July 30, 2023
Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessmentFederica Galimberti, Manuela Casula, Elena Olmastroni
Current Atherosclerosis Reports|November 25, 2024
Ezetimibe: Integrating Established Use with New Evidence - A Comprehensive ReviewElena Olmastroni, Stefano Scotti, Federica Galimberti, et al.
Atherosclerosis|July 22, 2025
Contribution and interaction of polygenic predisposition and family history of coronary heart disease in predicting cardiovascular riskFederica Galimberti, Elena Olmastroni, Manuela Casula, et al.
International Journal of Environmental Research and Public Health|March 11, 2023
Impact of COVID-19 Pandemic on Adherence to Chronic Therapies: A Systematic ReviewElena Olmastroni, Federica Galimberti, Elena Tragni, et al.
European Journal of Preventive Cardiology|May 22, 2026
Efficacy and Safety of Oral PCSK9 Inhibitors: Insights from a Meta-analysis of RCTSElena Olmastroni, Sining Xie, Federica Galimberti, et al.
Frontiers in Pharmacology|December 26, 2022
Beta-blockers in post-acute myocardial infarction patients: Drug prescription patterns from 2018 to Italy's first wave of the COVID-19 pandemicElena Olmastroni, Federica Galimberti, Alberico L Catapano, et al.
Journal of Internal Medicine|November 14, 2025
Colchicine and cardiovascular events: An updated meta-analysis of published randomized controlled trialsSining Xie, Federica Galimberti, Elena Olmastroni, et al.
European Journal of Preventive Cardiology|April 22, 2026
Effect of angiopoietin-like protein 3 inhibitors on lipid profile and other biomarkers: a meta-analysis of randomized controlled trialsSining Xie, Federica Galimberti, Elena Olmastroni, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 1, 2026
Comparative safety of lipid-lowering drugs alone or in combination: insights from a systematic review and network meta-analysisSining Xie, Federica Galimberti, Elena Olmastroni, et al.
Pharmacy (Basel, Switzerland)|February 25, 2025
Operational Definitions of Polypharmacy and Their Association with All-Cause Hospitalization Risk: A Conceptual Framework Using Administrative DatabasesStefano Scotti, Lorenza Scotti, Federica Galimberti, et al.
Pageof 4